Literature DB >> 6759366

Werner's syndrome: a review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations.

D Salk.   

Abstract

Werner's syndrome is a rare, autosomal recessive condition with multiple progeroid features, but it is an imitation of aging rather than accelerated or premature senescence. Somatic chromosome aberrations occur in multiple tissues in vivo and in vitro, and there is an increased incidence of neoplasia. Thus. Werner's syndrome can be classified in the group of chromosome instability syndromes. Recent findings provide additional support for the concept that there is an aberration of connective tissue metabolism in Werner's syndrome, but it is unclear whether this is a primary or secondary manifestation of the underlying genetic defect. Abnormal growth characteristics are observed in cultured skin fibroblast-like cells and this provides another avenue for current research. Identification of the basic genetic defect in Werner's syndrome might clarify our understanding of the normal aging process in general, or might elucidate specific aspects such as the development of neoplasia, atherosclerosis, diabetes, or osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759366     DOI: 10.1007/bf00295598

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  113 in total

1.  Heat-labile enzymes in Werner's syndrome fibroblasts.

Authors:  S Goldstein; E J Moerman
Journal:  Nature       Date:  1975-05-08       Impact factor: 49.962

2.  Observations of de novo clones of cytogentically aberrant cells in primary fibroblast cell strains from phenotypically normal women.

Authors:  L G Littlefield; J B Mailhes
Journal:  Am J Hum Genet       Date:  1975-03       Impact factor: 11.025

3.  [Another case of meningioma in a patient with Werner's syndrome].

Authors:  W Hoppe; H D Koritsch
Journal:  Psychiatr Neurol Med Psychol (Leipz)       Date:  1972-10

4.  Growth factors adherent to cell substrate are mitogenically active in situ.

Authors:  J C Smith; J P Singh; J S Lillquist; D S Goon; C D Stiles
Journal:  Nature       Date:  1982-03-11       Impact factor: 49.962

5.  Short communication lysosomal and mitochondrial heat labile enzymes in Werner's syndrome fibroblasts.

Authors:  A Houben; A Houbion; J Remacle
Journal:  Exp Gerontol       Date:  1980       Impact factor: 4.032

6.  [The Werner syndrome].

Authors:  T Gottesmann; L Zala; A Vogel; M Mumenthaler
Journal:  Schweiz Med Wochenschr       Date:  1980-02-16

7.  A mechanism of x chromosome aneuploidy in lymphocytes of aging women.

Authors:  P H Fitzgerald
Journal:  Humangenetik       Date:  1975-06-19

8.  Variegated translocation mosaicism in human skin fibroblast cultures.

Authors:  H Hoehn; E M Bryant; K Au; T H Norwood; H Boman; G M Martin
Journal:  Cytogenet Cell Genet       Date:  1975

9.  Evidence contrary to the protein error hypothesis for in vitro senescence.

Authors:  W R Pendergrass; G M Martin; P Bornstein
Journal:  J Cell Physiol       Date:  1976-01       Impact factor: 6.384

10.  Changes in the sulfated proteoglycans synthesized by "aging" chondrocytes. II. Organ-cultured vertebral columns.

Authors:  S A Fellini; M Pacifici; H Holtzer
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

View more
  47 in total

1.  Mutations in the WRN gene in mice accelerate mortality in a p53-null background.

Authors:  D B Lombard; C Beard; B Johnson; R A Marciniak; J Dausman; R Bronson; J E Buhlmann; R Lipman; R Curry; A Sharpe; R Jaenisch; L Guarente
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 2.  Ascorbate improves metabolic abnormalities in Wrn mutant mice but not the free radical scavenger catechin.

Authors:  Michel Lebel; Laurent Massip; Chantal Garand; Eric Thorin
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

3.  Telomere instability in a human tumor cell line expressing a dominant-negative WRN protein.

Authors:  Yongli Bai; John P Murnane
Journal:  Hum Genet       Date:  2003-06-25       Impact factor: 4.132

4.  A novel Werner Syndrome mutation: pharmacological treatment by read-through of nonsense mutations and epigenetic therapies.

Authors:  Ruben Agrelo; Miguel Arocena Sutz; Fernando Setien; Fabian Aldunate; Manel Esteller; Valeria Da Costa; Ricardo Achenbach
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

5.  Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.

Authors:  Ruben Agrelo; Wen-Hsing Cheng; Fernando Setien; Santiago Ropero; Jesus Espada; Mario F Fraga; Michel Herranz; Maria F Paz; Montserrat Sanchez-Cespedes; Maria Jesus Artiga; David Guerrero; Antoni Castells; Cayetano von Kobbe; Vilhelm A Bohr; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-24       Impact factor: 11.205

6.  Hyperinsulinemia and insulin resistance in Wrn null mice fed a diabetogenic diet.

Authors:  Gina Moore; Susan Knoblaugh; Kathryn Gollahon; Peter Rabinovitch; Warren Ladiges
Journal:  Mech Ageing Dev       Date:  2008-01-17       Impact factor: 5.432

7.  Werner's syndrome.

Authors:  G Rosenthal; V Assa; T Monos; B Biedner; T Lifshitz; H Zirkin; E Finkelstein; A Lazarov
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

8.  Bilateral combined hamartoma of the retina and the retinal pigment epithelium.

Authors:  J H Meyer; H Witschel
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

9.  Mutations in the consensus helicase domains of the Werner syndrome gene. Werner's Syndrome Collaborative Group.

Authors:  C E Yu; J Oshima; E M Wijsman; J Nakura; T Miki; C Piussan; S Matthews; Y H Fu; J Mulligan; G M Martin; G D Schellenberg
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 10.  From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.

Authors:  L S Cox; R G A Faragher
Journal:  Cell Mol Life Sci       Date:  2007-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.